Clinical Trial Update: iDAP Injection in the Treatment of Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial is evaluating iDAP injections for Parkinson's disease and is not yet recruiting. The sponsor listed is Anhui Provincial Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• iDAP Injection

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Parkinson Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING